Early intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with onconeural antibodies
Giulia Berzero, Evgenia Karantoni, Caroline Dehais, François Ducray, Laure Thomas, Géraldine Picard, Véronique Rogemond, Gaëlle Candelier, Jean-Philippe Camdessanché, Jean-Christophe Antoine, Jérôme De Seze, Amélie Liou-Schischmanoff, Jérôme Honnorat, Jean-Yves Delattre, Dimitri Psimaras, Giulia Berzero, Evgenia Karantoni, Caroline Dehais, François Ducray, Laure Thomas, Géraldine Picard, Véronique Rogemond, Gaëlle Candelier, Jean-Philippe Camdessanché, Jean-Christophe Antoine, Jérôme De Seze, Amélie Liou-Schischmanoff, Jérôme Honnorat, Jean-Yves Delattre, Dimitri Psimaras
No abstract availableKeywords: cancer treatment; immunotherapy; intravenous immunoglobulin; onconeural antibodies; paraneoplastic neurological syndromes.
Conflict of interest statement
Competing interests: JH received speaker honoraria from CSL Behring.
References
- Keime-Guibert F, Graus F, Broët P, et al. . Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999;53:1719–23. 10.1212/WNL.53.8.1719
- Graus F, Keime-Guibert F, Reñe R, et al. . Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients. Brain 2001;124(Pt 6):1138–48. 10.1093/brain/124.6.1138
- Uchuya M, Graus F, Vega F, et al. . Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies. J Neurol Neurosurg Psychiatry 1996;60:388–92. 10.1136/jnnp.60.4.388
- Widdess-Walsh P, Tavee JO, Schuele S, et al. . Response to intravenous immunoglobulin in anti-Yo associated paraneoplastic cerebellar degeneration: case report and review of the literature. J Neurooncol 2003;63:187–90. 10.1023/A:1023931501503
- Graus F, Delattre JY, Antoine JC, et al. . Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135–40. 10.1136/jnnp.2003.034447
Source: PubMed